In a preliminary study a single extra-amniotic injection of 1-5 mg of prostaglandin E, incorporated into an aqueous viscous gel was given to 24 patients to induce mid-trimester abortion. Twenty patients aborted within 24 hours, and the mean induction-abortion interval (± S.E. of mean) was 13-5 ± 15 hours. Vomiting occurred in seven patients, and transient severe uterine cramps, pallor, nausea, and shivering occurred in one patient immediately after the injection. Complete abortion occurred in 20 patients. A delay in the time taken to abort seemed to be associated with an immediate and rapid rise in uterine tone after the injection which required prompt analgesia; this probably reflected rapid decidual absorption and dissolution of the prostaglandins away from their site of action. The degree of distention of the catheter-retaining balloon did not influence abortion times.
Introduction
The clinical usefulness of prostaglandins for the induction of mid-trimester abortion has been established. Current studies aim at improving the efficacy of techniques and simplifying the method of drug administration.
The intra-amniotic route of administration has been modified to induce abortion within 24 hours by giving two injections with an interval of six hours between them (MacKenzie et al., 1974) or by a single injection combining the prostaglandin with a hypertonic solution (Bowen-Simpkins, 1973; Craft, 1973) . Current techniques of extra-amniotic administration (Embrey et al., 1972; Miller et al., 1972; Lippert and Modly, 1973; Midwinter et al., 1973) involve intermittent injections or slow continuous infusions throughout the abortion procedure. Recent experience with 15S-15-methyl prostaglandin F,X in a viscous medium as a single extra-amniotic injection has given good results (Wiqvist et al., 1974) .
We report here the results of induction of abortion by a single extra-amniotic injection of prostaglandin E, (PGE,) in a viscous aqueous hydroxyethylmethylcellulose gel.
Patients and Methods
Twenty-four patients (12 primigravidae, 12 multiparae) with a mean gestation of 15-1 weeks were studied: 23 patients were in the second trimester (range [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] six multiparae) had a mean abortion time of 13-2 ± 1 8 hours compared with 14-0 ± 2-8 hours when the balloon was distended with only 5 ml water, but this difference was not statistically significant. No correlation was apparent between gestation, parity, and abortion time.
Side effects observed were vomiting in seven cases (29-1 %) and a reaction (pallor, shivering, marked uterine pain, nausea) in one patient immediately after the injection, which persisted for 45 minutes. In one patient mild hypertension was recorded for which no treatment was necessary. No hypotension or pyrexia over 38°C occurred. Twenty patients (83-3%) aborted completely and did not require subsequent curettage. Three patients lost more than 250 ml of blood at abortion, in one of whom the loss amounted to an estimated 1000 ml and a transfusion was needed.
An average of two analgesic injections per patient were given for control of painful contractions. Two patients needed no analgesia during the abortion period and two further patients needed four injections. In seven patients the initial injection of papaveretum was necessary within 60 minutes of the extraamniotic prostaglandin instillation.
Analysis of the extra-amniotic tocographic records of 17 patients showed that there were two different forms of initial response by the uterus to the injected prostaglandin ( fig. 2) 
Discussion
At 12-15 weeks gestation, when amniocentesis is technically difficult and vaginal aspiration is hazardous, the extra-amniotic administration of prostaglandin is the method of choice in terminating pregnancy. With gestations greater than 15 weeks intra-or extra-amniotic administration of prostaglandins may be used.
Intra-amniotic administration of PGE2 alone (MacKenzie et al., 1974) or in combination with a hypertonic solution of urea (Bowen-Simpkins, 1973; Craft, 1973) or glucose (I. Z. MacKenzie, M. P. Embrey, K. Hillier, unpublished data) has been shown reliably to induce abortion in 24 hours in almost 100% of cases and to require only one or two intra-amniotic injections. Previously reported series of extra-amniotic prostaglandin administration have used intermittent injections, usually at two-hourly intervals, until abortion (Embrey et al., 1972) or a slow continuous infusion (Miller et al., 1972; Midwinter et al., 1973) of prostaglandins into the extra-amniotic space. The mean abortion times and success rates within 24 hours in these series are similar to those we obtained.
The administration of large extra-amniotic doses of PGE2
(500 yg, 1000 Hg, or 1500 zg in 3 ml or 9 ml sterile water) in this unit (I. Z. MacKenzie, M. P. Embrey, K. Hillier, unpublished data) has often caused marked reactions-that is, transient severe uterine pain, pallor, nausea, shivering, and hypotension-and has proved insufficiently reliable for inducing abortion within 24 hours. Radiological studies have suggested that possible reasons for these results could be the rapid absorption of prostaglandins into the systemic circulation and leakage through the cervix uteri (Wiqvist et al., 1972; MacKenzie and Hillier, 1974; Read et al., 1974) . A conscious attempt to reduce and delay leakage of prostaglandins and decidual absorption by incorporating them in a viscous gel, thus minimizing the necessity for frequent administrations, has produced good results and has decreased the incidence of postinjection reaction. Some leakage through the cervix was observed, however, in each of five cases when the viscous prostaglandin gel was coloured with dye though the volume of leakage was not quantified.
The two basic patterns of uterine pressure response to injection of prostaglandins may be indicative of the speed of initial drug absorption. Thus, an immediate rise in uterine tone suggests a rapid absorption and systemic dissolution of of drug necessitating early analgesia and resulting in long abortion times. A gradual increase in intrauterine tone probably indicates delayed absorption of prostaglandin, prolonging contact with the decidua and resulting in a shorter abortion time. Lippert and Modley (1973) reported the use of PGE2 in a 205% hydroxyethylmethylcellulose-based solution for midtrimester abortion. Intermittent extra-amniotic injections of 1-25 mg PGE2 in 0-5-ml volumes were administered using a thin polythene catheter at two-to three-hourly intervals until abortion in 14 patients. A mean abortion time of 11 hours 35 minutes was achieved with a mean total amount of 4 6 mg PGE, (range 2-5-7-5 mg). Compared with the present series the incidence of side effects was similar but in all their patients the placenta was spontaneously expelled; the percentage in which expulsion was complete is not clear. Bearing in mind the similarity of results the reasons for the very marked difference in the total amount of PGE2 injected between their patients and our patients are not obvious. The smaller volume and lower viscosity of the solution injected and the different catheter used may have influenced prostaglandin absorption and cervical leakage. It is also possible that repeated injections in their series were unnecessary. The very large doses of prostaglandins used did not result in overwhelming side effects, however. The comparatively short duration of action of the natural prostaglandins has been overcome by incorporating them into a high viscosity solution. The efficacy of the natural prostaglandin in this vehicle is comparable to that of the prostaglandin F2cx analogue, 15S 15-methyl PGF2c, in a viscous solution of 30% dextran 70 (Hyskon Pharmacia, Sweden) (Wiqvist et al., 1974) . The analogue does not seem to have any advantages over the natural compound PGE2.
Further improvement in efficacy might result from the use of larger doses of PGE2 but this preliminary study already shows the feasibility of a single extra-amniotic injection technique. For the patient this has clear advantages; it both avoids recourse to amniocentesis and obviates the need for repeated extra-amniotic injections while reducing the amount of nursing care required. Introduction Electrocardiographic (E.C.G.) abnormalities are known to occur in a variety of central nervous system lesions like subarachnoid haemorrhage, cerebrovascular accidents, head trauma, intracranial space-occupying lesions, meningitis, etc. (Byer et al., 1947; Burch et al., 1954; Schuster, 1960; Finkelstein and Nigaglioni, 1961; Hersch, 1961 Hersch, , 1964 Fentz and Gormsen, 1962; Goldman, 1967; Abildskov et al., 1970; Cruickshank and Dwyer, 1974) . Bradycardia, extrasystoles, abnormal ST-T deflection, tall, deeply inverted, or notched T waves, prominent U waves, and prolonged Q-T intervals have been described. The possible mechanism responsible for these changes has been discussed by Abildskov et al. (1970) , who concluded that the E.C.G. abnormalities may be mediated by abnormalities of the sympathetic tone to the heart. Raised intracranial pressure as judged by isolated readings of cerebrospinal fluid pressure at lumbar puncture was thought not to be responsible for E.C.G. abnormalities (Hersch, 1964) . It is now well established that intracranial pressure is not a static phenomenon and its dynamics can only be assessed by measuring it directly and continuously (Lundberg, 1960; Langfitt, 1969 He had sustained extensive cerebral contusion and his intracranial
